Author： Ambady Prakash Bettegowda Chetan Holdhoff Matthias
Publisher： Future Medicine
ISSN： 2045-0907
Source： CNS Oncology, Vol.2, Iss.6, 2013-11, pp. : 511-522
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
A promising light for an impossible disease: miRNAs in malignant gliomas
By Low Yin Yee Sharon Ng Wai Hoe
CNS Oncology, Vol. 2, Iss. 2, 2013-03 ,pp. :
Access to resources
Recommend
Microsurgery for Malignant Gliomas
By Yaşargil M. Kadri Paulo Yaşargil Dianne
Journal of Neuro-Oncology, Vol. 69, Iss. 1-3, 2004-08 ,pp. :
Blood-based biomarkers for malignant gliomas
Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. :
MGMT promoter methylation in malignant gliomas
Targeted Oncology, Vol. 5, Iss. 3, 2010-09 ,pp. :
Loss of heterozygosity analysis in malignant gliomas
Brain Tumor Pathology, Vol. 28, Iss. 3, 2011-07 ,pp. :